In this week’s edition of InnovationRx, we look at Summa Health’s first tech bets, the healthcare leaders on Forbes Veteran 250 list, BioMarin’s acquisition of an early-stage bone disease therapy, and more. To get it in your inbox, subscribe here.

Last October, venture capital firm General Catalyst paid $485 million to acquire Summa Health, a three-hospital health system serving five counties in northeast Ohio, on the theory that it could transform operations with new technology.

Today, Summa Health and General Catalyst announced the first wave of healthcare companies that the 8,000-employee health system is working with. They include Clarium, which uses AI to make hospital supply chains more efficient; voice AI agent company Hippocratic AI; tech-enabled pharmacy benefit manager Judi Health; and healthcare navigation firm Transcarent. All nine of the companies are–no surprise–backed by General Catalyst.

“The Amazon of healthcare is not a trillion-dollar company, but a trillion-dollar ecosystem,” Hemant Taneja, General Catalyst’s CEO and number 19 on this year’s Forbes Midas list of top investors, tells Forbes.

As Forbes previously detailed, Taneja had the idea of plugging a health system into Silicon Valley’s innovation engine. He believed that no healthcare provider would inject technology and AI into every step of its processes–so decided to do it himself.

“Everybody will tell you how hard it is to sell and implement at hospitals. The magic has been to say, ‘How do we cut through that inertia and move fast?” he says. The nine companies chosen to be part of Summa’ original tech ecosystem are “those that create demonstrable ROI from the get-go,” he adds.

Daryl Tol, acting CEO of........

© Forbes